المؤلفون: Lüder, Charina C., Michael, Tanja, Lass-Hennemann, Johanna, Schanz, Christian G., Venhorst, Andreas, Meyer, Tim, Equit, Monika

مصطلحات موضوعية: ddc:150, ddc:610, Trauma, PTSD, depression, adjuvant treatment, aerobic exercise training, narrative exposure therapy, traumafocused psychotherapy, refugee, TEPT, depresión, tratamiento adyuvante, entrenamiento aeróbico, terapia de exposición narrativa, psicoterapia enfocada en el trauma, refugiado

Relation: hdl:20.500.11880/37872

الاتاحة: http://nbn-resolving.org/urn:nbn:de:bsz:291--ds-422038
https://doi.org/10.22028/D291-42203
https://doi.org/10.1080/20008066.2023.2251777

المؤلفون: Ramón-Concepción, Iván, Soriano-García, Jorge Luis, Solórzano-González, Randy, Batista-Albuerne, Noyde, Lima-Pérez, Mayté, Duvergel-Calderín, Dayanis, Loys-Fernández, Jorge Lázaro, del Castillo-Carrillo, Concepción

المساهمون: MINSAP

المصدر: Revista Cubana de Investigaciones Biomédicas; Vol. 42 (2023) ; 1561-3011 ; 0864-0300

مصطلحات موضوعية: cáncer de mama temprano, HER2 positivo, tratamiento adyuvante, trastuzumab subcutáneo

وصف الملف: application/pdf

Relation: https://revibiomedica.sld.cu/index.php/ibi/article/view/2418/1162; https://revibiomedica.sld.cu/index.php/ibi/article/downloadSuppFile/2418/852; Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. doi:10.3322/caac.21551. 2. MINSAP. Anuario estadístico de Salud. La Habana: Ed 49. 2021. ISSN: 1561-4433. [acceso 12 enero de 2022]. Disponible en: http://bvscuba.sld.cu/anuario-estadisticode-cuba/ 3. Howlader N, Cronin KA, Kurian AW, Andridge R. Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiol Biomarkers Prev. 2018;27(6):619-26. doi:10.1158/1055-9965.EPI-17-0627. 4. Maadi H, Nami B, Tong J, Li G, Wang Z. The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2. BMC Cancer. 2018;18(1):238. doi:10.1186/s12885-018-4143-x. 5. Lupu R, Colomer R, Zugmaier G, Sarup J, Shepard M, Slamon D, et al. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Science. 1990;249(4976):1552-5. doi:10.1126/science.2218496. 6. Cameron D, Piccart-Gebhart MJ, Gelber RD, Procter M, Goldhirsch A, de Azambuja E, et al. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Lancet. 2017;389(10075):1195-1205. doi:10.1016/S0140-6736(16)32616-2. 7. Perez EA, Romond EH, Suman VJ, Jeong JH, Sledge G, Geyer CE Jr, et al. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2–positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. J Clin Oncol. 2014;32:3744-52. doi:10.1200/JCO.2014.55.5730. 8. Slamon DJ, Eiermann W, Robert NJ. Ten-year follow-up of the BCIRG-006 trial comparing doxorubicin plus cyclophosphamide followed by docetaxel (ACT) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (ACTH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer patients. Cancer Res. 2015;76(4suppl):S5-04. doi:10.1158/1538-7445.SABCS15-S5-04. 9. Ismael G, Hegg R, Muehlbauer S, Heinzmann D, Lum B, Kim SB, et al. Subcutaneous versus intravenous administration of (neo) adjuvant trastuzumab in patients with HER2–positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open–label, multicentre, randomized trial. Lancet Oncol. 2012;13(9):869-78. https://doi.org/10.1016/S1470-2045(12)70329-7 10. Genentech Inc. Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk injection, for subcutaneous use): US Prescribing Information. 2019. [Acceso 12 enero de 2022]. Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761106s000lbl.pdf 11. UK Medicines and Healthcare Products Regulatory Agency (MHRA). Electronic Medicines Compendium (EMC). Herceptin 600 mg Solution for Injection in Vial. [Acceso 12 enero de 2022]. Disponible en: https://www.medicines.org.uk/emc/product/1227/smpc 12. European Medicines Agency. Herceptin 150 mg powder for infusion and 600 mg solution for injection in vial: summary of product characteristics. 2019. [Acceso 12 enero de 2022]. Disponible en: https://www.ema.europa.eu/en/medicines/human/EPAR/herceptin 13. Soriano JL, Montejo N, Batista N, Loys J, Lima M, Castillo C, et al. Cáncer de mama en estadios tempranos. En: Soriano JL (Ed). Manual de Prácticas Médicas. Tomo 1 Unidad Funcional de Tumores. IV Edición. La Habana: Editorial de Ciencias Médicas; 2012. p. 21-89. 14. Edge S.B., Byrd D.R., Compton C.C., et al., eds. AJCC Cancer Staging Manual, 7th Edition. New York: springer; 2010 15. US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. 2017 [acceso: 15/01/2022]. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf 16. Early Breast Cancer Trialists’ Collaborative group (EBCTCG). Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials. Lancet Oncol. 2021;22(8):1139-50. doi:10.1016/S1470-2045(21)00288-6. 17. Ramón I, Soriano JL, Valenciano ML, Batista N, Lima M, Duvergel D, et al. Supervivencia de pacientes con cáncer mamario temprano HER2+ tratadas con trastuzumab endovenoso en adyuvancia. Rev Cuban Oncol. 2021 [acceso: 15/01/2022];19(1): e_91. Disponible en: https://revoncologia.sld.cu/index.php/onc/article/view/91 18. Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med. 2018;379(2):122-37. https://doi.org/10.1056/NEJMoa1803164. 19. Perrone F, De Laurentiis M, De Placido S, Orditura M, Cinieri S, Riccardi F, et al. Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. Eur J Cancer. 2019;118:178-86. https://doi.org/ 10.1016/j.ejca.2019.05.004 20. Li S, Wu J, Huang O, He J, Zhu L, Chen W, et al. Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2-patients. BMC Cancer. 2021;21:807. https://doi.org/10.1186/s12885-021-08555-4 21. Jackisch C, Hegg R, Stroyakovskiy D, Ahn JS, Melichar B, Chen SC, et al. HannaH phase III randomized study: association of total pathological complete response with event–free survival in HER2–positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment–free follow–up. Eur J Cancer. 2016; 62:62-75. http://dx.doi.org/10.1016/j.ejca.2016.03.087 22. Jackisch C, Stroyakovskiy D, Pivot X, Ahn JS, Melichar B, Chen SC, et al. Subcutaneous vs intravenous trastuzumab for patients with ERBB2-positive early breast cancer: Final analysis of the HannaH phase 3 randomized clinical trial. JAMA Oncol. 2019;5(5):e190339. doi:10.1001/jamaoncol.2019.0339. 23. Pivot X, Verma S, Fallowfield L, Müller V, Lichinitser M, Jenkins V, et al. Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study. Eur J Cancer. 2017;86:82-90. doi:10.1016/j.ejca.2017.08.019. 24. Schmidt M, KÜmmel S, Ruf-Doerdelmann A, Distelrath A, Wacker J, Schmatloch S, et al. Neo-adjuvant and/or adjuvant subcutaneous trastuzumab (Herceptin®) in patients with early her2-positive breast cancer: Real world data from a german observational study - (NIS HerSCin). Anticancer Res. 2021;41(1):485-96. doi:10.21873/anticanres.14799. 25. Heo YA, Syed YY. Subcutaneous trastuzumab: A review in HER2-positive breast cancer. Target Oncol. 2019;14(6):749-58. doi:10.1007/s11523-019-00684-y. 26. Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): followup of a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet Oncol. 2014;15(6):640-7. doi:10.1016/S1470-2045(14)70080-4 27. Untch M., Rezai M., Loibl S., Fasching P.A., Huober J., Tesch H., et al. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study. J Clin Oncol. 2010;28(12): 2024-2031. PMID: 20308670. DOI:10.1200/JCO.2009.23.8451 28. Untch M, Rezai M, Loibl S, Fasching PA, Huober J, Tesch H, et al. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups. J Clin Oncol. 2011;29(25): 3351-7. doi:10.1200/JCO.2010.31.4930 29. Van den Nest M, Glechner A, Gold M, Gartlehner G. The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review. Syst Rev. 2019;8(1):321. doi:10.1186/s13643-019-1235-x. 30. Jung KH, Ataseven B, Verrill M, Pivot X, De Laurentiis M, Al-Sakaff N, et al. Adjuvant subcutaneous trastuzumab for HER2-positive early breast cancer: Subgroup analyses of safety and active medical conditions by body weight in the SafeHer phase III study. Oncologist. 2018;23(10):1137-43. doi:10.1634/theoncologist.2018-0065. 31. Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, et al. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients. Eur J Cancer. 2017;82:237-246. doi:10.1016/j.ejca.2017.05.010.; https://revibiomedica.sld.cu/index.php/ibi/article/view/2418

الاتاحة: https://revibiomedica.sld.cu/index.php/ibi/article/view/2418

المؤلفون: Teles, Carlos Eduardo de Araújo, Tavares, Yonara Barreto, Oliveira, Alexandre Henrique Moura de

المصدر: Research, Society and Development; Vol. 11 No. 1; e31911125052 ; Research, Society and Development; Vol. 11 Núm. 1; e31911125052 ; Research, Society and Development; v. 11 n. 1; e31911125052 ; 2525-3409

مصطلحات موضوعية: Acupuntura, Disfunção da articulação temporomandibular, Tratamento coadjuvante, Disfunción de la articulación temporomandibular, Tratamiento adyuvante, Acupuncture, Temporomandibular joint dysfunction, Adjuvant treatment

وصف الملف: application/pdf

Relation: https://rsdjournal.org/index.php/rsd/article/view/25052/21922; https://rsdjournal.org/index.php/rsd/article/view/25052

الاتاحة: https://rsdjournal.org/index.php/rsd/article/view/25052
https://doi.org/10.33448/rsd-v11i1.25052

المؤلفون: Frisso, Jaqueline Menezes, Meneguelli, Mayra, Berndt, Felipe Mateus, Valverde, Rodrigo Montanari de Melo, Morelato Neto, Elias, Mendonça , Vanessa Gois de, Viana, Orlando Vitor Rocha, Silva , Maiky Marcelino Da, Silva, Fernando do Carmo, Muniz, Igor Mansur

المصدر: Research, Society and Development; Vol. 11 No. 14; e82111435969 ; Research, Society and Development; Vol. 11 Núm. 14; e82111435969 ; Research, Society and Development; v. 11 n. 14; e82111435969 ; 2525-3409

مصطلحات موضوعية: Ozônio, Tratamento advjuvante, Terapia, Ozono, Tratamiento Adyuvante, Ozone, Adjuvant treatment, Therapy

وصف الملف: application/pdf

Relation: https://rsdjournal.org/index.php/rsd/article/view/35969/30136; https://rsdjournal.org/index.php/rsd/article/view/35969

الاتاحة: https://rsdjournal.org/index.php/rsd/article/view/35969
https://doi.org/10.33448/rsd-v11i14.35969

المؤلفون: Tamayo-alonso, Pilar, Martín-gómez, Esther, García-talavera, Paloma, Cañadas-salazar, José, Peñaherrera-cepeda, Carolina, Díaz-gonzález, Luis Gonzaga

مصطلحات موضوعية: Differentiated thyroid cancer, radioactive iodine treatment, I-131, radioiodine refractory thyroid cancer, adjuvant therapy, Carcinoma diferenciado de tiroides, tratamiento con radioyodo, 131I, cáncer de tiroides refractario al radioiodo, tratamiento adyuvante

وصف الملف: application/pdf

Relation: Revista ORL, 12 (2021); http://hdl.handle.net/10366/148892

الاتاحة: http://hdl.handle.net/10366/148892

المؤلفون: Tamayo-Alonso, Pilar, Martín-Gómez, Esther, García-Talavera, Paloma, Cañadas-Salazar, José, Peñaherrera-Cepeda, Carolina, Díaz-González, Luis Gonzaga

المصدر: Revista ORL; Vol. 12 Núm. 4 (2021); 371-380 ; Revista ORL; Vol. 12 No. 4 (2021); 371-380 ; 2444-7986 ; 10.14201/orl.2021124

مصطلحات موضوعية: Differentiated thyroid cancer, radioactive iodine treatment, I-131, radioiodine refractory thyroid cancer, adjuvant therapy, Carcinoma diferenciado de tiroides, tratamiento con radioyodo, 131I, cáncer de tiroides refractario al radioiodo, tratamiento adyuvante

وصف الملف: application/pdf; text/html; text/xml; application/epub+zip

Relation: https://revistas.usal.es/index.php/2444-7986/article/view/25746/27457; https://revistas.usal.es/index.php/2444-7986/article/view/25746/27458; https://revistas.usal.es/index.php/2444-7986/article/view/25746/27459; https://revistas.usal.es/index.php/2444-7986/article/view/25746/27460; https://revistas.usal.es/index.php/2444-7986/article/view/25746

الاتاحة: https://revistas.usal.es/index.php/2444-7986/article/view/25746
https://doi.org/10.14201/orl.25746

المؤلفون: Ferrari, Natalia

المصدر: Diagnóstico; Vol. 60 Núm. 2 (2021); 92-97 ; 1018-2888 ; 2709-7951 ; 10.33734/diagnostico.v60i2

مصطلحات موضوعية: Gastric cancer, adjuvant treatment, neoadjuvant treatment, treatment of metastatic disease, systemic treatment, Cáncer gástrico, tratamiento adyuvante, tratamiento neoadyuvante, tratamiento de metástasis, tratamiento sistémico

وصف الملف: application/pdf; text/html

Relation: http://142.44.242.51/index.php/diagnostico/article/view/286/281; http://142.44.242.51/index.php/diagnostico/article/view/286/293; http://142.44.242.51/index.php/diagnostico/article/view/286

الاتاحة: http://142.44.242.51/index.php/diagnostico/article/view/286
https://doi.org/10.33734/diagnostico.v60i2.286

المؤلفون: Yardanis Hernández Fernández, Yereyni León Rodríguez, Zaadia Pérez Parra, Madelyn Jareño Ochoa, Mildrey Moreno Ramírez, María del Carmen Benítez Merino

المصدر: Revista Cubana de Oftalmología, Vol 33, Iss 1 (2020)

مصطلحات موضوعية: Pterigión recurrente, tratamiento adyuvante, alternativas terapéuticas, Ophthalmology, RE1-994

وصف الملف: electronic resource

Relation: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762020000100013&tlng=es; https://doaj.org/toc/1561-3070

URL الوصول: https://doaj.org/article/f509d699cc924dc79c861bbb9128c799

المؤلفون: Margarita Romeo, S. Martínez-Román, A. Tarrats, E. Carballas

المصدر: Clinica E Investigacion En Ginecologia Y Obstetricia
Clínica e Investigación en Ginecología y Obstetricia

مصطلحات موضوعية: Cross infection, biology, SARS-CoV-2, business.industry, pandemia, COVID-19, tratamiento adyuvante, Obstetrics and Gynecology, tumores ginecológicos, medicine.disease_cause, biology.organism_classification, Virology, Article, tratamiento quirúrgico, Reproductive Medicine, Obstetrics and Gynaecology, Pandemic, medicine, business, Coronavirus Infections, Betacoronavirus, Coronavirus

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab79a55b184c0a5b633ce709690487f0
https://doi.org/10.1016/j.gine.2020.06.001

المؤلفون: Teles, Carlos Eduardo de Araújo, Tavares, Yonara Barreto, Oliveira, Alexandre Henrique Moura de

المصدر: Research, Society and Development; Vol. 11 No. 1; e31911125052
Research, Society and Development; Vol. 11 Núm. 1; e31911125052
Research, Society and Development; v. 11 n. 1; e31911125052
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI

مصطلحات موضوعية: Disfunción de la articulación temporomandibular, Disfunção da articulação temporomandibular, Acupuntura, Acupuncture, Tratamento coadjuvante, Temporomandibular joint dysfunction, Tratamiento adyuvante, Adjuvant treatment

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3056::8f77412b48bbac017ec95158f8a7726e
https://rsdjournal.org/index.php/rsd/article/view/25052

المؤلفون: Prieto Bergua, Laura, Ortega Suárez, Daimaris

المساهمون: Martín Vasallo, Pablo, Pérez Rodríguez, Natalia, Grado En Medicina

مصطلحات موضوعية: Síndrome de Lynch, Cáncer de endometrio, Tratamiento adyuvante, Clasificación molecular, Inestabilidad de microsatélites

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3235::702c22545178c6279d33c48eb1448d1d
http://riull.ull.es/xmlui/handle/915/28663

المؤلفون: Miguel Martín, Javier Puente

المصدر: Psicooncologia, Vol 4, Iss 2, Pp 311-330 (2007)

مصطلحات موضوعية: Cáncer de mama, Quimioterapia, Tratamiento adyuvante, Tratamiento hormonal, Trastuzumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Psychology, BF1-990

وصف الملف: electronic resource

Relation: http://revistas.ucm.es/index.php/PSIC/article/view/16448; https://doaj.org/toc/1696-7240; https://doaj.org/toc/1988-8287

URL الوصول: https://doaj.org/article/626efea11ff745c98173b809f7a7e2a5

المؤلفون: José A Solis C

المصدر: Revista Chilena de Obstetricia y Ginecología, Vol 70, Iss 1, Pp 41-48 (2005)

مصطلحات موضوعية: Cáncer cérvico uterino etapa temprana, tratamiento adyuvante, factores de riesgo, Early stage cervical cancer, adjuvant therapy, risk factors, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

Relation: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262005000100010; https://doaj.org/toc/0048-766X; https://doaj.org/toc/0717-7526

URL الوصول: https://doaj.org/article/4ebdff629cc044fcaffa25c360e31a4a

المؤلفون: José Solis C., Mónica Silva V., Christian Frank K., Javier Egaña F., Soledad Martínez C., Luis Cortés R.

المصدر: Revista Chilena de Obstetricia y Ginecología, Vol 70, Iss 4, Pp 236-242 (2005)

مصطلحات موضوعية: Sarcoma uterino, leiomiosarcoma uterino, tratamiento adyuvante, Uterine sarcoma, uterine leiomyosarcoma, adjuvant treatment, Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

Relation: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262005000400006; https://doaj.org/toc/0048-766X; https://doaj.org/toc/0717-7526

URL الوصول: https://doaj.org/article/35b530b6a59e49b0833593f1462f1a33

المؤلفون: Ferrari, Natalia

المصدر: Diagnóstico; Vol. 60 Núm. 2 (2021); 92-97
Revistas Fundación Instituto Hipólito Unanue
Fundación Instituto Hipólito Unanue
instacron:FIHU

مصطلحات موضوعية: neoadjuvant treatment, tratamiento neoadyuvante, tratamiento de metástasis, Cáncer gástrico, adjuvant treatment, tratamiento adyuvante, tratamiento sistémico, systemic treatment, treatment of metastatic disease, Gastric cancer

وصف الملف: application/pdf; text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3056::99ce47179e264c9e4ef459cee669ccb4
http://142.44.242.51/index.php/diagnostico/article/view/286

المؤلفون: Tamayo-Alonso,Pilar, Martín-Gómez,Esther, García-Talavera,Paloma, Cañadas-Salazar,José, Peñaherrera-Cepeda,Carolina, Díaz-González,Luis

المصدر: Revista ORL v.12 n.4 2021

مصطلحات موضوعية: carcinoma diferenciado de tiroides, tratamiento con radioyodo, 131I, cáncer de tiroides refractario al radioiodo, tratamiento adyuvante

وصف الملف: text/html

الاتاحة: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2444-79862021000400009

المؤلفون: Tamayo Alonso, María Pilar, Martín Gómez, Esther, García-Talavera San Miguel, Paloma, Cañadas Salazar, Jose, Peñaherrera Cepeda, Andrea Carolina, Díaz González, Luis Gonzaga

المصدر: Revista ORL, ISSN 2444-7986, Vol. 12, Vol. 4, 2021, pags. 371-380

مصطلحات موضوعية: Differentiated thyroid cancer, radioactive iodine treatment, I-131, radioiodine refractory thyroid cancer, adjuvant therapy, Carcinoma diferenciado de tiroides, tratamiento con radioyodo, 131I, cáncer de tiroides refractario al radioiodo, tratamiento adyuvante

وصف الملف: application/pdf

Relation: https://dialnet.unirioja.es/servlet/oaiart?codigo=8324783; (Revista) ISSN 2444-7986

الاتاحة: https://dialnet.unirioja.es/servlet/oaiart?codigo=8324783

المؤلفون: Victoria Ibarra, Ruth Ortiz, Nora Gómez, Israel González, Julio Torales, Marcos Almirón

المصدر: Anales de la Facultad de Ciencias Médicas (Asunción), Volume: 51, Issue: 3, Pages: 27-32, Published: DEC 2018

مصطلحات موضوعية: Psychotherapist, business.industry, medicine.medical_treatment, adjuvant treatment, tratamiento adyuvante, Physical exercise, General Medicine, Ejercicio físico, trastornos mentales, mental disorders, medicine, Narrative review, business, Adjuvant

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b0eaf3e3ad0d7611e7ac91dbe8e99f
https://doi.org/10.18004/anales/2018.051(03)27-032

المؤلفون: Martín, Miguel, Puente, Javier

المصدر: Psicooncología; Vol 4, No 2-3 (2007); 311 - 330 ; 1988-8287 ; 1696-7240

مصطلحات موضوعية: Cáncer de mama, Quimioterapia, Tratamiento adyuvante, Tratamiento hormonal, Trastuzumab, Breast cancer, Chemotherapy, Adjuvant systemic therapy, Hormonal therapy

وصف الملف: application/pdf

Relation: https://revistas.ucm.es/index.php/PSIC/article/view/PSIC0707220311A/15593; https://revistas.ucm.es/index.php/PSIC/article/view/PSIC0707220311A

الاتاحة: https://revistas.ucm.es/index.php/PSIC/article/view/PSIC0707220311A

المؤلفون: García-Granero, E. (E.), Chirivella, I. (Isabel), Cervantes, A. (Andrés)

مصطلحات موضوعية: Adjuvant therapy, Rectal cancer, Colon cancer, Tratamiento adyuvante, Cáncer de recto, Cáncer de colon, Materias Investigacion::Ciencias de la Salud

وصف الملف: application/pdf

Relation: https://hdl.handle.net/10171/39675

الاتاحة: https://hdl.handle.net/10171/39675